GE recruits new allies
GE Medical Systems has signed licensing agreements with the Texas A&M University system and Beth Israel Deaconess Medical Center to develop new near-infrared-light imaging technologies. Efforts will focus on assessing the potential of these technologies
GE Medical Systems has signed licensing agreements with the Texas A&M University system and Beth Israel Deaconess Medical Center to develop new near-infrared-light imaging technologies. Efforts will focus on assessing the potential of these technologies to improve the detection, diagnosis, and treatment of cancers. The licensing agreements call for GE to work with the research institutions to advance technologies there for eventual FDA approval.
The A&M system technology, fluorescence-enhanced optical imaging and tomography, combines imaging sensitivity, tissue penetration, and tissue characterization as the means to detect and track disease progression. It also might be used in the development of new diagnostic and therapeutic agents. The Beth Israel Deaconess technology is an intraoperative near-infrared fluorescence imaging system that enables surgeons to visualize surgical anatomy and functional fluorescence simultaneously, noninvasively, and with high spatial resolution. Potential applications include image-guided sentinel lymph node mapping, image-guided cancer resection with real-time assessment of surgical margins, mapping of tumor and normal vasculature, image-guided avoidance of critical structures such as nerves, and detection of occult metastases.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
